BIOL

Biolase, Inc.
BIOL

Overview Fund Activity
Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

26 hedge funds and large institutions have $1.42M invested in Biolase, Inc. in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.

Holders
26
Holders Change
+5
Holders Change %
+23.81%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
1
Sabby Management
Florida
$92K
2
VF
2
Virtu Financial
New York
$74K
3
Citadel Advisors
3
Citadel Advisors
Florida
$49K
4
TRCT
4
Tower Research Capital (TRC)
New York
$8K
5
UBS Group
5
UBS Group
Switzerland
$13K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$0
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$213K
3
Jane Street
3
Jane Street
New York
$15K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$0
5
Northern Trust
5
Northern Trust
Illinois
$11K
Name Holding Trade Value Shares
Change 		Shares
Change %
Millennium Management
26
Millennium Management
New York
$4 +$4 +5 New
Renaissance Technologies
27
Renaissance Technologies
New York
– -$252K -218 Closed
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
– -$11K -10 Closed
1
2